These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 32777161)
1. Distribution and prognostic significance of gluconeogenesis and glycolysis in lung cancer. Smolle E; Leko P; Stacher-Priehse E; Brcic L; El-Heliebi A; Hofmann L; Quehenberger F; Hrzenjak A; Popper HH; Olschewski H; Leithner K Mol Oncol; 2020 Nov; 14(11):2853-2867. PubMed ID: 32777161 [TBL] [Abstract][Full Text] [Related]
2. Dysregulation of phosphoenolpyruvate carboxykinase in cancers: A comprehensive analysis. Xue S; Cai Y; Liu J; Ji K; Yi P; Long H; Zhang X; Li P; Song Y Cell Signal; 2024 Aug; 120():111198. PubMed ID: 38697449 [TBL] [Abstract][Full Text] [Related]
3. PCK2 activation mediates an adaptive response to glucose depletion in lung cancer. Leithner K; Hrzenjak A; Trötzmüller M; Moustafa T; Köfeler HC; Wohlkoenig C; Stacher E; Lindenmann J; Harris AL; Olschewski A; Olschewski H Oncogene; 2015 Feb; 34(8):1044-50. PubMed ID: 24632615 [TBL] [Abstract][Full Text] [Related]
4. Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway? Grasmann G; Smolle E; Olschewski H; Leithner K Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):24-36. PubMed ID: 31152822 [TBL] [Abstract][Full Text] [Related]
5. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4. Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways. Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256 [TBL] [Abstract][Full Text] [Related]
8. Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor-positive breast cancer via regulation of the mTOR pathway. Hsu HP; Chu PY; Chang TM; Huang KW; Hung WC; Jiang SS; Lin HY; Tsai HJ Cancer Med; 2023 Jan; 12(2):1588-1601. PubMed ID: 35757841 [TBL] [Abstract][Full Text] [Related]
9. Cancer Cells Hijack Gluconeogenic Enzymes to Fuel Cell Growth. Balsa-Martinez E; Puigserver P Mol Cell; 2015 Nov; 60(4):509-11. PubMed ID: 26590709 [TBL] [Abstract][Full Text] [Related]
10. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Goodwin J; Neugent ML; Lee SY; Choe JH; Choi H; Jenkins DMR; Ruthenborg RJ; Robinson MW; Jeong JY; Wake M; Abe H; Takeda N; Endo H; Inoue M; Xuan Z; Yoo H; Chen M; Ahn JM; Minna JD; Helke KL; Singh PK; Shackelford DB; Kim JW Nat Commun; 2017 May; 8():15503. PubMed ID: 28548087 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia increases the rate of renal gluconeogenesis via hypoxia-inducible factor-1-dependent activation of phosphoenolpyruvate carboxykinase expression. Owczarek A; Gieczewska K; Jarzyna R; Jagielski AK; Kiersztan A; Gruza A; Winiarska K Biochimie; 2020; 171-172():31-37. PubMed ID: 32045650 [TBL] [Abstract][Full Text] [Related]
12. Association of mitochondrial phosphoenolpyruvate carboxykinase with prognosis and immune regulation in hepatocellular carcinoma. Li C; Zhang ED; Ye Y; Xiao Z; Huang H; Zeng Z Sci Rep; 2024 Jun; 14(1):14051. PubMed ID: 38890507 [TBL] [Abstract][Full Text] [Related]
13. PCK2 opposes mitochondrial respiration and maintains the redox balance in starved lung cancer cells. Bluemel G; Planque M; Madreiter-Sokolowski CT; Haitzmann T; Hrzenjak A; Graier WF; Fendt SM; Olschewski H; Leithner K Free Radic Biol Med; 2021 Nov; 176():34-45. PubMed ID: 34520823 [TBL] [Abstract][Full Text] [Related]
14. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters. Koh YW; Lee SJ; Park SY Lung Cancer; 2017 Feb; 104():31-37. PubMed ID: 28212997 [TBL] [Abstract][Full Text] [Related]
15. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis. Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer. Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797 [TBL] [Abstract][Full Text] [Related]
18. Pck-ing up steam: Widening the salmonid gluconeogenic gene duplication trail. Marandel L; Kostyniuk DJ; Best C; Forbes JLI; Liu J; Panserat S; Mennigen JA Gene; 2019 May; 698():129-140. PubMed ID: 30849535 [TBL] [Abstract][Full Text] [Related]
19. Phosphoenolpyruvate carboxykinase 2-mediated metabolism promotes lung tumorigenesis by inhibiting mitochondrial-associated apoptotic cell death. Zhang J; He W; Liu D; Zhang W; Qin H; Zhang S; Cheng A; Li Q; Wang F Front Pharmacol; 2024; 15():1434988. PubMed ID: 39193344 [TBL] [Abstract][Full Text] [Related]
20. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data. Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]